Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 481 participants.
Also called NCT02928497
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 481 participants
- Sponsor
- Registry
-
NCT02928497
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, Czechia, Denmark, Germany, Italy, Netherlands, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT02928497. Randomized; no masking; primary purpose prevention. Start 2017-02-06 (actual); primary completion 2025-09-23 (actual). Results posted on 2026-08-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
- Acronym
- ASAP-TOO
- Condition
- Stroke
- Intervention (Device)
- WATCHMAN LAAC Device Implant
- Intervention (Drug)
- Single Antiplatelet Therapy or No Therapy (Control)
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02928497- Content hash
b7e2eea181562188b41e565cea26730a6f7f5e2035256253770397e4ed255df9